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Grade≥2 toxicity, there were 3 and 1 patient with pneumonitis Grades 2 and 3, respectively; one patient had Grade 2 diarrhea;
and one patient experienced Grade 3 lower gastrointestinal hemorrhage. On univariate analysis, having a longer time from the
primary tumor diagnosis date to the oligometastasis was associated with lower risk of mortality (P=0.03). In contrast, the lack
of complete/partial response (P=0.04) or having a greater oligometastasis size (HR=4.5; P=0.01) was associated with higher risk
of mortality. On multivariate analysis, only the response to the HT retained signiﬁcance (P=0.01).
Conclusions. Hypofractionated image-guided HT is well tolerated and offers adequate local control with low acute morbidity in
patients with extracraneal oligometastatic disease. We found that the response to HT was the only predictor for OS.
http://dx.doi.org/10.1016/j.rpor.2013.03.556
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Introduction. Stereotactic body radiation therapy (SBRT) is a novel treatment modality in radiation oncology that delivers a very
high dose of radiation to the tumor target with high precision using single or a small number of fractions. SBRT is the result of
technological advances in patient/tumor immobilization, image guidance, and treatment planning and delivery. This modality
is safe and effective in both early stage primary cancer and oligometastases.
Objective. We present our experience in the treatment of primary and metastatic tumors with SBRT.
Methods. BetweenApril 2012 andFebruary 2013, 22 patientswith 24different locationsunderwent SBRT for primary andmetastatic
tumors using CT and/or PET-CT for diagnosis. Treatment was made using vacuum body ﬁxation and abdominal compression (in
some cases) to reduce intrafractional organ motion. We made three planning CTs in all patients: free breathing, inhalation and
exhalation. Internal target volume (ITV) was delineated based on fusion of three CTs. Planning target volume (PTV) was then
determined by adding additional setup margin to ITV. The locations of the treatments were distributed as follows: 11 primary
lung tumors, 6 lung metastases, 3 adrenal metastasis, 3 lymph node metastasis and 1 vertebral metastases. We have made
different fraction schemes, from 12Gy in 5 fractions (60Gy) until 4Gy in 10 fractions (40Gy).
Results. The acute toxicity has been excellent, appearing only G1 pneumonitis. Assessment of response was performed with CT
and/or PET-CT, with a 80% of local control.
Conclusions. SBRT is a treatment option for many inoperable patients with primary and metastatic tumors and provides a great
beneﬁt, because of its high efﬁciency, with a control of lesions in more than 85% of cases, and excellent clinical tolerance due to
lowest toxicity.
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Purpose. We have analyzed our experience with stereotactic body radiation therapy (SBRT) in lung tumors. We have determined
our treatment accuracy using Bodyﬁx® as immobilization system and conebeam CT (CBCT) for image guidance, and the set-up
and treatment times using different planning systems.
Methods and materials. We have studied the patients treated from August 2011 to December 2012. Every patient underwent
4DCT after immobilization with Bodyﬁx®. We contoured the internal target volume (ITV) and we created a planning tar-
get volume (PTV) with a 5mm expansion. A stereotactic RT plan was designed using 7–9 coplanar and noncoplanar ﬁelds,
dynamic arcs or a combination of both of them. Before each fraction a CBCT was made for image guidance. We have mea-
sured the set-up time (total time in treatment room minus beam-on time) and the treatment time (beam-on time), comparing
the length of treatment between different RT plans. We have made CBCT after treatment to study the intrafraction tumor
movements.
Results. Eighteen patients have been treated. Nine patients were treated with ﬁxed ﬁelds, seven with dynamic arcs and two with
a combination of arcs and ﬁelds. Mean times for treatment were 10.4min, 4.3min and 4min, respectively, being arc-therapy
signiﬁcantly faster than ﬁxed ﬁelds treatment (p=0.006). First fraction set-up mean time was 35.7min, signiﬁcantly longer than
overall set-up mean time, that was 27.8min (p<0.05). The mean intrafraction tumor motion was 0.2 cm (0–0.4) in AP, 0.2 cm
(0.1–0.5) in SI and 0.2 cm (0–0.5) in ML direction.
